Digital Genome Market is Progressing Towards a Strong Growth By 2026

Digital Genome Market Size, Share, Trend,
Outlook, Future Growth Analysis And
Synthesis 2018 - 2026
Digital genome is one of the emerging technologies in DNA sequencing, which allows to perform human
genome to be sequenced and digitized in minutes and at the cost of only a few hundred dollars. This is
specifically more efficient than the first sequencing of the 3.2 billion base pairs of a DNA that make up
the human genome, which took many years and cost millions of dollars to completely sequenced. Such
continuous advancement in the field of digital genome enables to deliver rapid and cost-effective DNA
sequencing for development of personalized medicine and clinical treatment.
The Global Digital Genome Market is estimated to be valued at US$ 7,594.8 million in 2018, and is
expected to witness a CAGR of 10.9% during the forecast period (2018–2026).
Ask for In-depth Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/136
Increasing Technological Advancement in Digital Genome field is expected to augment the Market
Growth
Increasing technological advancements and growing awareness related to use of genomes for diagnosis of
diseases such as cancer, diabetes, and Attention Deficit Hyperactivity Disorder (ADHD) are expected to
drive growth of the digital genome market. For instance, in February 2018, the National Human Genome
Research Institute (NHGRI) launched a strategic planning, which will establish a 2020, vision for
genomics research aimed at accelerating scientific and medical breakthroughs. Furthermore, in the
development of this strategic planning, the institute will engage experts and diverse public communities
to identify diverse areas of genomics, which will expand the novel applications in human health and
disease treatments.
Increasing Adoption of Personalized Medicine is expected to propel the Market Growth
Increasing inclination towards using genome to predict reaction of medication for safe and effective
treatment of cancer, Attention Deficit Hyperactivity Disorder (ADHD), diabetes for personalized and safe
treatment to choose most appropriate treatment for ADHD, and nutrition profiling where DNA is used to
prevent development of chronic diseases are expected to be major growth drivers for the digital genome
market.
Report includes chapters which deeply display the following deliverable about industry :
• Digital Genome Market Research Objective and Assumption
• Digital Genome Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Digital Genome Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Digital Genome Market, By Regions
• Digital Genome Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Digital Genome Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Digital Genome Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Digital Genome Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Digital Genome Market - Key Players
Key players operating in the global digital genome market include, Illumina, Inc., PerkinElmer, Inc.,
Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies
Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC, Amazon.com, Inc., Deep
Genomics, Deep Genomics, Deep Genomics, Desktop Genetics Ltd., and Ancestry.com LLC.
Detailed Segmentation:
Global Digital Genome Market, By Product Type:
•
Sequencer & Analyzers
•
Reagents & Kits
•
Sequencing & Analysis Software
Global Digital Genome Market, By Application:
•
Clinical
- Reproductive Health
- Oncology
- Others
•
Forensics
•
Drug Discovery and Development
•
Other Applications
Find the comprehensive research report here with a single click:
https://www.coherentmarketinsights.com/market-insight/digital-genome-market-136
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

The Global Digital Genome Market is estimated to be valued at US$ 7,594.8 million in 2018, and is expected to witness a CAGR of 10.9% By 2026.